We examined a possible association of single-nucleotide polymorphisms (SNPs) in the promoters of IL-3, IL-4, and IL-13 genes on the 5q31-33, IL-3 À16T4C, IL-4 À590T4C, and IL-13 À1055C4T, with severity of malaria in 361 adult malaria patients in Thailand. The IL-13 À1055T allele showed a significant association with protection from severe malaria (OR 0.51, 95% CI 0.32-0.80; P ¼ 0.0032 by the w 2 test), while allele frequencies of IL-3 À16T4C and IL-4 À590T4C were not statistically different between mild and severe malaria patients. An IL-13 À1055C4T has been reported to alter the regulation of IL-13 production. Thus, IL-13 À1055T may show resistance to severe malaria through the alteration of IL-13 production.
Introduction
The human chromosome 5q31-33 region contains a number of interleukin genes considered to play an important role in the pathogenesis of malaria. 1, 2 Recently, the 5q31-33 region was reported to be linked to Plasmodium falciparum blood infection levels in Burkina Faso. 3 Moreover, this region is known to show linkage to plasma immunoglobulin E (IgE) levels 4, 5 and schistosomiasis infection. 6, 7 It is therefore interesting to analyze genes in this region for detecting variants associated with susceptibility or resistance to severe malaria.
Interleukin genes such as IL-3, IL-4, IL-5, IL-9, IL-12B, and IL-13 are clustered on the 5q31-33 region. To date, variation screening has been extensively performed for these genes, and several single-nucleotide polymorphisms (SNPs) have been found to show functional significance and to be associated with immune-related diseases. An SNP at À16 in the promoter of IL-3 (IL-3 À16T4C) has been reported to be strongly associated with rheumatoid arthritis, although functional significance of this SNP remains unclear. 8 An SNP located at À590 upstream of the open reading frame of IL-4 (IL-4 À590C4T) has been reported to influence the promoter activity and to be associated with the total serum IgE. 9 More recently, this polymorphism was found to be associated with elevated antibody levels against malaria antigens in the Fulani of West Africa. 10 An IL-13 promoter polymorphism, IL-13 À1055C4T, is known to affect the expression level and to be associated with allergic asthma 11 and chronic obstructive pulmonary disease. 12 These observations raise the question of whether the IL-3 À16T4C, IL-4 À590C4T, and IL-13 À1055C4T polymorphisms are associated with severity of malaria. Thus, we examined a possible association of these SNPs with susceptibility or resistance to severe malaria in Thai malaria patients.
Results and discussion Table 1 shows a significant association of the IL-13 À1055T allele with protection from severe malaria in Thai malaria patients (OR 0.51, 95% CI 0.32-0.80; P ¼ 0.0032 by the w 2 test). In addition, since Armitage's test for trend yielded a small P-value (P ¼ 0.0050), IL-13 À1055T appears to have a dosage effect on the protection. In contrast, no statistically significant difference in frequency of IL-3 and IL-4 promoter polymorphisms was detected. The C to T change at À1055 of IL-13 has been suggested to alter IL-13 production through the binding of NF-AT to the IL-13 promoter. 11 Although the role of IL-13 in the host defense or the pathogenesis of severe malaria has not been established yet, increased production of IL-13 may prevent the onset of severe malaria. The biological significance of IL-13 in malaria patients should be clarified in future studies.
Previously, we found that longer forms of CCTTT microsatellite repeat (number of repeats X15) in the inducible nitric oxide synthase (iNOS) promoter are associated with susceptibility to severe malaria in the present set of malaria patients. 13 In order to examine the interaction between iNOS and IL-13 polymorphisms, we reassessed the effect of IL-13 À1055T on protection from severe malaria after stratification by possession of longer iNOS alleles. With longer alleles (ie, risk alleles for severe malaria), Armitage's test for trend revealed a marginally significant association of IL-13 À1055T with protection from severe malaria (P ¼ 0.0502). Without longer alleles, no association was detected. Thus, the protective effect of IL-13 À1055T may be evident particularly in individuals with longer iNOS alleles. In this study, the À1055C4T polymorphism was analyzed in the IL-13 gene. However, an apparent association of IL-13 À1055T with protection from severe malaria can arise from linkage disequilibrium between IL-13 À1055C4T and a primarily associated polymorphism. Although we cannot exclude such a possibility from this study, we can discuss it based on estimated three-SNP haplotype frequencies (Table 2 ). Table 2 shows that estimated frequencies of all haplotypes with IL-13 À1055T are higher in patients with mild malaria than in those with severe malaria, although a likelihood ratio test did not suggest the significant difference in haplotype frequencies between the two patient groups because of the high degree of freedom. If there is a primary polymorphism with a rare protective allele (eg, with a population frequency of o0.03) around the IL-13 À1055C4T polymorphism, the rare allele is expected to lie on one of four possible haplotypes with IL-13 À1055T, and such a haplotype as with the protective allele would be frequently observed in mild malaria patients compared with severe malaria patients, and the remaining haplotypes would be equally observed in mild and severe malaria patients. However, there was no predominant haplotype with IL-13 À1055T occurring at a high frequency in mild malaria patients as shown in Table 2 . Therefore, the detected association is unlikely to be because of a strong linkage disequilibrium with the other primary polymorphism with a rare protective allele. Table 3 shows estimated two-SNP haplotype frequencies and pairwise D 0 . Since minor allele frequencies of examined SNPs are high and the sample size is large, D 0 is considered to be a good indicator for assessing the degree of linkage disequilibrium. No significant linkage disequilibrium was observed among three SNPs (ie, D 0 o 0.25), implying that either IL-13 À1055C4T itself or polymorphism being in linkage disequilibrium with IL-13 À1055C4T is associated with protection from severe malaria independently of IL-4 À590C4T and IL-3 À16T4C. In addition, even if there is a primarily associated polymorphism other than IL-13 À1055C4T, A likelihood ratio test revealed no significant difference in distribution of haplotype frequencies between mild and severe malaria patients. Constructing a detailed map of polymorphisms around the IL-13 gene and describing a profile of linkage disequilibrium among them will be helpful for further studies on the association of IL-13 polymorphism with severe malaria. Although the present result should be replicated in independent studies and in other ethnic populations, our study is consistent with a previous study, 3 having argued that 5q31-33 is an important region for influencing the clinical outcome of malaria.
Patients and methods

Patients
In this study, 164 adult patients with severe P. falciparum malaria and 197 adult patients with mild malaria (as controls) living near the border between Thai and Myanmar (in northwest Thailand) were enrolled. All patients underwent treatment at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University. For all patients, malarial infection by P. falciparum was confirmed by a positive blood smear for the asexual form of P. falciparum. Clinical manifestations of severe and mild malaria were classified according to the following definitions and criteria. A patient with severe malaria was defined as one with one of the following signs: high parasitemia (4100 000 parasite/ml), hypoglycemia (glucose o22 nmol/l), severe anemia (hematocrit o20% or hemoglobin o7.0 g/dl), and a serum creatinine level of more than 3.0 mg/dl. In the present study, patients with cerebral malaria were not included in severe malaria patients. Mild malaria was characterized by fever without other underlying causes of infections and no manifestations of severe malaria as described above. All individuals were 13 years of age or older, and the mean ages of patients with mild malaria and those with severe malaria were 25.3 and 23.8 years, respectively. This study was approved by the institute review board of the Faculty of Tropical Medicine, Mahidol University and informed consent was obtained from all patients.
In order to examine a possibility that our samples had been taken from a heterogeneous population, the HLA-B and -DRB1 genes were analyzed for the same samples in advance. Since HLA-B and -DRB1 genes are highly polymorphic, a comparison of the allele frequencies between mild and severe malaria patients allows us to detect the presence of population stratification. As a result, there was no marked difference in allele frequencies of these genes between them (unpublished data). Thus, we may conclude that our patients were free from population stratification.
DNA extraction
Genomic DNA was extracted from peripheral blood leukocytes using a QIAamp blood kit (Qiagen, Hilden, Germany).
Genotyping of IL-3 À16T4C, IL-4 À590T4C, and IL-13 À1055C4T polymorphisms In order to detect the IL-3 À16T4C, IL-4 À590T4C, and IL-13 À1055C4T polymorphisms, a direct sequencing was firstly performed with an ABI PRISMt 3100 Genetic Analyzer (Perkin-Elmer Applied Biosystems). PCR was performed using the following sets of primers: a 5 for IL-4 À590T4C, and a 5 0 primer IL13 À1055F: 5 0 -GTGGGGG-TTTCTGGAG-3' and a 3' primer IL13 À1055R: 5'-GTGT-CTGGCCCCTTTAATTTAA-3' for IL-13 À1055C4T. The amplification conditions consisted of an initial denaturation at 961C for 10 min, followed by 35 cycles of denaturation at 961C for 30 s, annealing at 581C for 30 s, and extension at 721C for 1 min for IL-3 À16T4C and for 30 s for IL-4 À590T4C using a thermal cycler (GeneAmp PCR system 9700; Perkin-Elmer Applied Biosystems). For IL-13 À1055C4T, the amplification conditions consisted of an initial denaturation at 951C for 5 min, followed by 32 cycles of denaturation at 951C for 1 min, annealing at 551C for 1 min, and extension at 721C for 1 min using a thermal cycler.
All genotypes were detected by the direct sequencing at first and which were used as references in the PCRsingle-strand conformation polymorphism (PCR-SSCP) analysis. A measure of 2 ml of solution containing the PCR product was mixed with 6 ml of denaturing solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF). The mixtures were denatured at 961C for 5 min and immediately cooled on ice. A volume of l ml of the mixtures was applied to 10% polyacrylamide gel (acrylamide : bisacrylamide ¼ 49 : 1) containing 5.0% glycerol for IL-3 À16T4C and to 10% polyacrylamide gel for IL-4 À590T4C, and to 7.5% polyacrylamide gel for IL-13 À1055C4T. Electrophoresis was carried out for 90 min in 0.5 Â TBE (45 mM Tris-borate (pH 8.0), 1 mM EDTA) at 151C for IL-3 À16T4C, at 101C for IL-4 À590T4C, and at 161C for IL-13 À1055C4T under a constant current of 20 mA/gel, using a minigel electrophoresis apparatus with a constant temperature control system (90 Â 80 Â 1 mm 3 , AE 6410 and AE 6370; ATTO, Tokyo, Japan). Single-strand DNA fragments in the gel were visualized by silver staining (Daiichi Pure Chemicals, Tokyo, Japan).
Statistical analysis
The genotype and allele frequencies of the IL-3 À16T4C, IL-4 À590T4C, and IL-13 À1055C4T polymorphisms were compared between mild and severe malaria patients using the w 2 test. In addition, Armitage's test for trend was performed for genotype data. The maximum-likelihood haplotype frequencies for three SNPs were calculated using the EH program, 14 which is based on an expectation-maximization (EM) algorithm. In the EM algorithm, the logarithm of likelihood of the sample, ln L, was maximized in each malaria group. In order to compare the estimated three-SNP haplotype frequency distribution between mild and severe malaria patients, a likelihood-ratio test was performed. The likelihood-ratio statistic was defined by LR ¼ 2[ln(L mild )+ln(L severe )Àln(L mild+severe )], which had an approximate w 2 distribution with seven degrees of freedom. The frequencies of haplotypes defined by two SNPs were estimated by summing over the estimated frequencies of three-SNP haplotypes (ie, the collapsing procedure was used), and then Lewontin's D' values 15 between two SNPs were calculated.
